Found: 17
Select item for more details and to access through your institution.
Sorafenib plus drug-eluting bead transarterial chemoembolization for early intrahepatic stage-progressed advanced hepatocellular carcinoma refractory to conventional transarterial chemoembolization.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 5, p. 1873, doi. 10.1007/s00432-022-04107-w
- By:
- Publication type:
- Article
Identifying optimal candidates for post-TIPS patients with HCC undergoing TACE: a multicenter observational study.
- Published in:
- European Radiology, 2023, v. 33, n. 4, p. 2809, doi. 10.1007/s00330-022-09249-6
- By:
- Publication type:
- Article
Analysis of HCV Isolates Among the Li Ethnic in Hainan Island of South China Reveals Their HCV-6 Unique Evolution and a New Subtype.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2018, v. 50, n. 5, p. 1832, doi. 10.1159/000494863
- By:
- Publication type:
- Article
Genotype Distribution and Molecular Epidemiology of Hepatitis C Virus in Guangzhou, China: Predominance of Genotype 1b and Increasing Incidence of Genotype 6a.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2017, v. 43, n. 2, p. 775, doi. 10.1159/000481561
- By:
- Publication type:
- Article
Hepatic Tumor Stiffness Measured by Shear Wave Elastography Is Prognostic for HCC Progression Following Treatment With Anti-PD-1 Antibodies Plus Lenvatinib: A Retrospective Analysis of Two Independent Cohorts.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.868809
- By:
- Publication type:
- Article
Spleen‐dedicated stiffness measurement performed well to rule out high‐risk varices in HBV‐related hepatocellular carcinoma: Screening for high‐risk varices in HCC.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 5, p. 680, doi. 10.1111/apt.17850
- By:
- Publication type:
- Article
Withdrawn: Effectiveness and safety of toripalimab, camrelizumab and sintilimab in a real‐world cohort of hepatitis B virus associated hepatocellular carcinoma patients.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 10, p. 2102, doi. 10.1111/bcp.14452
- By:
- Publication type:
- Article
A different inhibitor is required for overcoming entecavir resistance: a comparison of four rescue therapies in a retrospective study.
- Published in:
- British Journal of Clinical Pharmacology, 2017, v. 83, n. 10, p. 2259, doi. 10.1111/bcp.13330
- By:
- Publication type:
- Article
Transarterial chemoembolization with/without immune checkpoint inhibitors plus tyrosine kinase inhibitors for unresectable hepatocellular carcinoma: a single center, propensity score matching real-world study.
- Published in:
- Discover Oncology, 2024, v. 15, n. 1, p. 1, doi. 10.1007/s12672-024-00917-1
- By:
- Publication type:
- Article
Serum-derived hepatitis C virus can infect human glioblastoma cell line SF268 and activate the PI3K-Akt pathway.
- Published in:
- Molecular Medicine Reports, 2019, v. 19, n. 5, p. 4441
- By:
- Publication type:
- Article
Antiviral therapy improves the survival rate and decreases recurrences and fatalities in liver cancer patients following curative resection: A meta-analysis.
- Published in:
- Molecular & Clinical Oncology, 2015, v. 3, n. 6, p. 1239, doi. 10.3892/mco.2015.614
- By:
- Publication type:
- Article
Development and Validation of a Contrast-Enhanced CT-Based Radiomics Nomogram for Prediction of Therapeutic Efficacy of Anti-PD-1 Antibodies in Advanced HCC Patients.
- Published in:
- Frontiers in Immunology, 2021, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.613946
- By:
- Publication type:
- Article
A novel engineered IL-21 receptor arms T-cell receptor-engineered T cells (TCR-T cells) against hepatocellular carcinoma.
- Published in:
- Signal Transduction & Targeted Therapy, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41392-024-01792-6
- By:
- Publication type:
- Article
Lenvatinib Plus Camrelizumab vs. Lenvatinib Monotherapy as First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Cohort Study.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.809709
- By:
- Publication type:
- Article
Sofosbuvir-Based Therapies for Patients with Hepatitis C Virus Infection: Real-World Experience in China.
- Published in:
- Canadian Journal of Gastroenterology & Hepatology, 2018, p. 1, doi. 10.1155/2018/3908767
- By:
- Publication type:
- Article
Safety and Efficacy of Camrelizumab Combined with Apatinib for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Multicenter Retrospective Study.
- Published in:
- OncoTargets & Therapy, 2020, v. 13, p. 12683, doi. 10.2147/OTT.S286169
- By:
- Publication type:
- Article
Interaction between baseline HBV loads and the prognosis of patients with HCC receiving anti-PD-1 in combination with antiangiogenic therapy undergoing concurrent TAF prophylaxis.
- Published in:
- 2022
- By:
- Publication type:
- journal article